atorvastatin Articles
Tokyo pharma stocks - week to May 20
27 May 2002
Pfizer's Lipitor prices questioned in Europe
20 May 2002
New Zetia data back up product rationale
13 May 2002
Tokyo pharma stocks - week to May 6
13 May 2002
Pfizer 1st-qtr EPS increases 18%
22 April 2002
World drug sales up 12% in year to Feb
22 April 2002
France's top-selling Rx drugs in 2001
15 April 2002
Lescol cuts cardiac events after PCI
25 March 2002
Zetia boosts response to statin therapy
25 March 2002
AstraZeneca confident about overcoming loss of Prilosec revenues
11 February 2002
Tokyo pharma stocks - week to January 28
4 February 2002
Genaissance completes enrollment in STRENGTH II study.
21 January 2002
Actelion licenses Tracleer to Neopharm in Israel
12 December 2001
World drug sales up 11% in year to Sept
3 December 2001
Lipitor boosts Yamanouchi sales
12 November 2001
Stock Commentary - Tokyo
1 November 2001
BioMerieux-Pierre Fabre licenses pitavastatin
31 October 2001
Tokyo pharma stocks - week to October 29
30 October 2001
Genaissance begins second STRENGTH study
19 October 2001
Stock Commentary - Tokyo
18 October 2001
Japan pharma stock market - week to October 15
17 October 2001
World retail drug sales grew 11% in 12 months to July 2001, reports IMS
28 September 2001
Viagra, a best-seller for Pfizer Malaysia
28 September 2001
Analysts comment on Crestor safety data
14 September 2001
Crestor "as safe as other statins"
13 September 2001
Low awareness level of cholesterol risk
5 September 2001
US state seniors Rx costs compared globally
18 July 2001
Update - Pfizer second-quarter net income leaps 31%
18 July 2001
Lipitor to be tested in Alzheimer's
12 July 2001
Pfizer's UK cardiovascular patient initiative
12 July 2001
AstraZeneca: Crestor filed, Viozan pulled
28 June 2001
Sankyo planning to cut 1,000 jobs
6 June 2001
Crestor can protect blood vessels
21 May 2001
Yamanouchi sets out five-year strategy
30 April 2001
Novartis licenses super statin
26 April 2001
Pfizer 1st-qtr 2001 net income rises 34%
23 April 2001
Pravastatin action on CRP a class effect?
17 April 2001
Lipitor cuts stroke in patients with ACS; MIRACL
11 April 2001
Tokyo pharma stock market - week to March 26, 2001
27 March 2001
40%-123% US Rx price variations found
13 February 2001
Morepen looks to grow in the USA
2 February 2001
Stock Commentary - Tokyo
25 January 2001
Stroke prevention emerges from heart disease
10 January 2001
Stock Commentary - Tokyo
14 December 2000
Pfizer forecasts strong revenue growth in 2001-2002 at R&D meeting
14 December 2000
Merck & Co reiterates independence at pipeline presentation
14 December 2000
Antithrombotic delay mars upbeat AstraZeneca R&D meeting
13 December 2000
Mevalotin sales holding up at Sankyo
27 November 2000
Yamanouchi sales up on forecasts
13 November 2000
Stock Commentary - Tokyo
26 October 2000
B-MS net earnings increase 13%
23 October 2000
Stock Commentary Tokyo
28 September 2000
Stock Commentary Tokyo
17 August 2000
Stock Commentary Tokyo
3 August 2000
Sankyo seeks FDA OK for hypertension drug
1 August 2000
Stock Commentary Tokyo
27 July 2000
B-MS up on strong sales of Glucophage
24 July 2000
Pfizer leads 1st-qtr US physician detailing
11 July 2000
Stock Commentary Tokyo
6 July 2000
Stock Commentary Europe
6 July 2000
Stock Commentary Tokyo
29 June 2000
Merck's Zocor lowers CRP
29 June 2000
Japan Lipitor launch: a threat for statins
19 June 2000
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
